Pharmaceuticals - Morocco

Morocco

The Pharmaceuticals market in Morocco is expected to achieve revenue of US$643.10m in 2024.
Among the various markets, Oncology Drugs is projected to be the largest, with a market volume of US$118.10m in 2024.
The sector is anticipated to witness a steady annual growth rate (CAGR 2024-2028) of 6.39%, leading to a market volume of US$824.00m by 2028.
When compared globally, United States is predicted to generate the highest revenue, amounting to US$636.90bn in 2024.
The pharmaceutical market in Morocco has experienced significant growth in recent years, driven by increasing government investment in healthcare infrastructure.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

Morocco has been experiencing a significant growth in the Pharmaceuticals market in recent years.

Customer preferences: Moroccan customers are becoming more health-conscious and are increasingly seeking out high-quality pharmaceutical products. The demand for over-the-counter (OTC) drugs is on the rise, as consumers are looking for more accessible and affordable healthcare options. Additionally, there is a growing demand for generic drugs due to their lower cost compared to branded drugs.

Trends in the market: The Pharmaceuticals market in Morocco is witnessing a trend towards increased investment in research and development by local and international pharmaceutical companies. This investment is aimed at developing new and innovative drugs to meet the growing demand for high-quality pharmaceutical products. There is also a growing trend towards the use of e-commerce platforms for the distribution of pharmaceutical products, which is helping to increase access to healthcare in remote areas.

Local special circumstances: Morocco has a well-developed healthcare system that is supported by a network of public and private hospitals, clinics, and pharmacies. The government is also taking steps to improve access to healthcare in rural areas by investing in healthcare infrastructure and providing subsidies for healthcare services. Additionally, Morocco has a strategic location, which makes it an attractive market for pharmaceutical companies looking to expand their operations in Africa and the Middle East.

Underlying macroeconomic factors: Morocco's economy has been growing steadily over the past few years, with a focus on diversification and modernization. The government has implemented a number of economic reforms aimed at improving the business environment and attracting foreign investment. This has helped to create a favorable environment for pharmaceutical companies looking to invest in Morocco. Additionally, Morocco has a young and growing population, which is driving demand for healthcare services and pharmaceutical products.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.